Showing 4 of 24 recruiting trials for “medullary-thyroid-carcinoma”
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
RecruitingNCT03765333 ↗
GETNE Registration of Thyroid Cancer
👨⚕️ Jorge Hernando Cubero, M.D., Hospital Universitari Vall d'Hebron, Barcelona📍 1 site📅 Started May 2019View details ↗
RecruitingNCT07199127 ↗
Duodenal Polyposis Classification in FAP
👨⚕️ Marco Vitellaro, M.D., Fondazione IRCCS Istituto Nazionale dei Tumori, Milano📍 2 sites📅 Started Feb 2018View details ↗
RecruitingNCT04104230 ↗
Quebec Pancreas Cancer Study
👨⚕️ George Zogopoulos, MD, PhD, McGill University Health Centre/Research Institute of the McGill University Health Centre📍 1 site📅 Started Mar 2012View details ↗
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →